tiprankstipranks
Nuo Therapeutics Inc (AURX)
:AURX
US Market

Nuo Therapeutics (AURX) Price & Analysis

Compare
11 Followers

AURX Stock Chart & Stats


---

Financials

Quarterly

Ownership Overview

43.40%56.60%
43.40% Insiders
Mutual Funds
― Other Institutional Investors
56.60% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

AURX FAQ

What was Nuo Therapeutics Inc’s price range in the past 12 months?
Nuo Therapeutics Inc lowest stock price was $0.25 and its highest was $1.76 in the past 12 months.
    What is Nuo Therapeutics Inc’s market cap?
    Nuo Therapeutics Inc’s market cap is $56.85M.
      When is Nuo Therapeutics Inc’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Nuo Therapeutics Inc’s earnings last quarter?
      Currently, no data Available
      Is Nuo Therapeutics Inc overvalued?
      According to Wall Street analysts Nuo Therapeutics Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Nuo Therapeutics Inc pay dividends?
        Nuo Therapeutics Inc does not currently pay dividends.
        What is Nuo Therapeutics Inc’s EPS estimate?
        Nuo Therapeutics Inc’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Nuo Therapeutics Inc have?
        Nuo Therapeutics Inc has 46,598,404 shares outstanding.
          What happened to Nuo Therapeutics Inc’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Nuo Therapeutics Inc?
          Currently, no hedge funds are holding shares in AURX
          ---

          Company Description

          Nuo Therapeutics Inc

          Nuo Therapeutics, Inc. engages in developing and marketing products for chronic wound care. It offers Aurix point of care technology for the safe and efficient separation of autologous blood to produce a platelet based therapy for the chronic wound care market. The company was founded on April 29, 1998 and is headquartered in Gaithersburg, MD.
          ---
          Similar Stocks
          Company
          Price & Change
          Follow
          Cyclacel Pharmaceuticals
          Protalix
          Avinger
          Moleculin Biotech
          Popular Stocks
          ---
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis